{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T16:10:51Z","timestamp":1790439051357,"version":"4.1.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T00:00:00Z","timestamp":1745020800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinical-genitourinary-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Genitourinary Cancer"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.clgc.2025.102364","type":"journal-article","created":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T12:04:56Z","timestamp":1745323496000},"page":"102364","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Integrating Genomic Classifiers and Nonsuspicious Magnetic Resonance Imaging Findings in Predictive Modelling for Lymph Node Metastasis in Patients With Localized Prostate Cancer"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8027-6661","authenticated-orcid":false,"given":"Vinayak G.","family":"Wagaskar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7107-0933","authenticated-orcid":false,"given":"Ashutosh","family":"Maheshwari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6930-289X","authenticated-orcid":false,"given":"Osama","family":"Zaytoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-3420-1578","authenticated-orcid":false,"given":"Yashaswini","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaushik P.","family":"Kolanukuduru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4149-0486","authenticated-orcid":false,"given":"Neeraja","family":"Tillu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2934-1189","authenticated-orcid":false,"given":"Manish K.","family":"Choudhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ash K.","family":"Tewari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.clgc.2025.102364_bib0001","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.eururo.2020.09.042","article-title":"EAU-EANM-ESTRO-ESUR-SIOG Guidelines on prostate Cancer-2020 update. Part 1: screening, diagnosis, and local treatment with curative intent","volume":"79","author":"Mottet","year":"2021","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.clgc.2025.102364_bib0002","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.eururo.2007.07.035","article-title":"The template of the primary lymphatic landing sites of the prostate should be revisited: results of a multimodality mapping study","volume":"53","author":"Mattei","year":"2008","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.clgc.2025.102364_bib0003","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.eururo.2016.12.003","article-title":"The benefits and harms of different extents of lymph node dissection during radical prostatectomy for prostate cancer: a systematic review","volume":"72","author":"Fossati","year":"2017","journal-title":"Eur Urol"},{"issue":"4","key":"10.1016\/j.clgc.2025.102364_bib0004","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.eururo.2017.03.049","article-title":"Development and internal validation of a novel model to identify the candidates for extended pelvic lymph node dissection in prostate cancer","volume":"72","author":"Gandaglia","year":"2017","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.clgc.2025.102364_bib0005","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.eururo.2011.10.044","article-title":"Updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection: the essential importance of percentage of positive cores","volume":"61","author":"Briganti","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.clgc.2025.102364_bib0006","unstructured":"Memorial Sloan Kettering Cancer Center. Dynamic prostate cancer nomogram: coefficients. www.mskcc.org\/nomograms\/prostate\/pre-op\/coefficients. Accessed December 12, 2024."},{"issue":"3","key":"10.1016\/j.clgc.2025.102364_bib0007","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/bju.14066","article-title":"Identifying candidates for super-extended staging pelvic lymph node dissection among patients with high-risk prostate cancer","volume":"121","author":"Gandaglia","year":"2018","journal-title":"BJU Int"},{"issue":"3","key":"10.1016\/j.clgc.2025.102364_bib0008","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.euf.2017.11.013","article-title":"A head-to-head comparison of four prognostic models for prediction of lymph node invasion in African American and Caucasian individuals","volume":"5","author":"Bandini","year":"2019","journal-title":"Eur Urol Focus"},{"issue":"3","key":"10.1016\/j.clgc.2025.102364_bib0009","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.eururo.2018.10.012","article-title":"A novel nomogram to identify candidates for extended pelvic lymph node dissection among patients with clinically localized prostate cancer diagnosed with Magnetic resonance imaging-targeted and systematic biopsies","volume":"75","author":"Gandaglia","year":"2019","journal-title":"Eur Urol"},{"issue":"4","key":"10.1016\/j.clgc.2025.102364_bib0010","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.eururo.2018.05.014","article-title":"The diverse genomic landscape of clinically low-risk prostate cancer","volume":"74","author":"Cooperberg","year":"2018","journal-title":"Eur Urol"},{"issue":"4","key":"10.1016\/j.clgc.2025.102364_bib0011","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1097\/JU.0000000000000290","article-title":"A 17-gene genomic prostate score as a predictor of adverse pathology in men on active surveillance","volume":"202","author":"Kornberg","year":"2019","journal-title":"J Urol"},{"issue":"3","key":"10.1016\/j.clgc.2025.102364_bib0012","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.eururo.2020.11.021","article-title":"A systematic review of the evidence for the decipher genomic classifier in prostate cancer","volume":"79","author":"Jairath","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.clgc.2025.102364_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.euo.2024.06.007","article-title":"Use of decipher prostate biopsy test in patients with favorable-risk disease undergoing conservative management or radical prostatectomy in the surveillance, epidemiology, and end results registry","author":"Zhu","year":"2024","journal-title":"Eur Urol Oncol"},{"issue":"3","key":"10.1016\/j.clgc.2025.102364_bib0014","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jmoldx.2015.12.006","article-title":"Application of a clinical whole-transcriptome assay for staging and prognosis of prostate cancer diagnosed in needle core biopsy specimens","volume":"18","author":"Knudsen","year":"2016","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.clgc.2025.102364_bib0015","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.euros.2021.03.008","article-title":"Clinical utility of negative multiparametric magnetic resonance imaging in the diagnosis of prostate cancer and clinically significant prostate cancer","volume":"28","author":"Wagaskar","year":"2021","journal-title":"Eur Urol Open Sci"},{"issue":"1","key":"10.1016\/j.clgc.2025.102364_bib0016","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.eururo.2015.08.052","article-title":"PI-RADS prostate imaging - reporting and data system: 2015, version 2","volume":"69","author":"Weinreb","year":"2016","journal-title":"Eur Urol"},{"issue":"8","key":"10.1016\/j.clgc.2025.102364_bib0017","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.ctrv.2012.05.005","article-title":"Management of prostate cancer patients with lymph node involvement: a rapidly evolving paradigm","volume":"38","author":"Cr\u00e9hange","year":"2012","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.clgc.2025.102364_bib0018","unstructured":"Explainable Machine Learning Platform. https:\/\/www.neuraldesigner.com\/. Accessed December 12, 2024."},{"issue":"8","key":"10.1016\/j.clgc.2025.102364_bib0019","doi-asserted-by":"crossref","first-page":"14107","DOI":"10.18632\/oncotarget.12959","article-title":"Different imaging techniques for the detection of pelvic lymph nodes metastasis from gynecological malignancies: a systematic review and meta-analysis","volume":"8","author":"Gong","year":"2017","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.clgc.2025.102364_bib0020","doi-asserted-by":"crossref","first-page":"W95","DOI":"10.2214\/AJR.17.18481","article-title":"The diagnostic performance of MRI for detection of lymph node metastasis in bladder and prostate cancer: an updated systematic review and diagnostic meta-analysis","volume":"210","author":"Woo","year":"2018","journal-title":"Am J Roentgenol"},{"issue":"6","key":"10.1016\/j.clgc.2025.102364_bib0021","doi-asserted-by":"crossref","first-page":"255","DOI":"10.4103\/UROS.UROS_28_19","article-title":"Smaller prostate volume is associated with adverse pathological features and biochemical recurrence after radical prostatectomy","volume":"30","author":"Buie","year":"2019","journal-title":"Urolog Sci"},{"issue":"1","key":"10.1016\/j.clgc.2025.102364_bib0022","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/pros.1046","article-title":"High-grade prostate cancer is associated with low serum testosterone levels","volume":"47","author":"Schatzl","year":"2001","journal-title":"Prostate"},{"issue":"30","key":"10.1016\/j.clgc.2025.102364_bib0023","doi-asserted-by":"crossref","first-page":"7546","DOI":"10.1200\/JCO.2005.05.525","article-title":"Prostate size and risk of high-grade, advanced prostate cancer and biochemical progression after radical prostatectomy: a search database study","volume":"23","author":"Freedland","year":"2005","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.clgc.2025.102364_bib0024","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/s41391-019-0167-9","article-title":"Decipher identifies men with otherwise clinically favorable-intermediate risk disease who may not be good candidates for active surveillance","volume":"23","author":"Herlemann","year":"2020","journal-title":"Prostate Cancer Prostat Dis"},{"issue":"3","key":"10.1016\/j.clgc.2025.102364_bib0025","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/s41391-018-0101-6","article-title":"Validation of the decipher test for predicting adverse pathology in candidates for prostate cancer active surveillance","volume":"22","author":"Kim","year":"2019","journal-title":"Prostate Cancer Prostat Dis"},{"issue":"2","key":"10.1016\/j.clgc.2025.102364_bib0026","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.eururo.2017.03.036","article-title":"Validation of a genomic risk classifier to predict prostate cancer-specific mortality in men with adverse pathologic features","volume":"73","author":"Karnes","year":"2018","journal-title":"Eur Urol"}],"container-title":["Clinical Genitourinary Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767325000655?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767325000655?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T19:53:12Z","timestamp":1752609192000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1558767325000655"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S1558767325000655"],"URL":"https:\/\/doi.org\/10.1016\/j.clgc.2025.102364","relation":{},"ISSN":["1558-7673"],"issn-type":[{"value":"1558-7673","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Integrating Genomic Classifiers and Nonsuspicious Magnetic Resonance Imaging Findings in Predictive Modelling for Lymph Node Metastasis in Patients With Localized Prostate Cancer","name":"articletitle","label":"Article Title"},{"value":"Clinical Genitourinary Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clgc.2025.102364","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102364"}}